EverGlade Insights Blog
Executive Summary BARDA’s suspension of funding for COVID-19 therapeutics risks repeating mistakes of past pandemics as it may cause industry to pull out of the development space, experts say. Industry sources are concerned the Biden...
The DPA Title III program just received an additional $10B in the recovery legislation that was recently passed. The DPA program is administered by the US Air Force and more information can be found here...
Recently we became aware of two new opportunities for federal funding through HHS and DoD. We believe these may present exciting new avenues for companies that work in these areas. First, BARDA just posted two...
Recently, the Coalition for Epidemic Preparedness Innovations (CEPI) published a call for proposals that is open from 28 JAN 2021 to 28 MAY 2021 and can be found here [CEPICfPCallText.pdf]. Trials that expand access in...
Recently BARDA published information about the COVID programs the USG is supporting through collaboration between HHS and DoD. Some of that information is summarized in the table below. In the rush to respond to the...
The Biomedical Advanced Research and Development Authority (BARDA) recently published a Presolicitation Notice for a project titled ‘BARDA Chemical Animal Model Development” [beta.SAM.gov | Search]. The Notice announces BARDA’s intention to publish an RFP for...